يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"FALS, Familial ALS"', وقت الاستعلام: 1.02s تنقيح النتائج
  1. 1

    المصدر: Regenerative Therapy, Vol 11, Iss, Pp 143-166 (2019)
    Regenerative Therapy

    مصطلحات موضوعية: 0301 basic medicine, Ropinirole hydrochloride, ALP, Alkaline phosphatase, SOD, Superoxide dismutase, ALS, Amyotrophic lateral sclerosis, 0302 clinical medicine, HDL, High-density lipoprotein, Amyotrophic lateral sclerosis, APTT, Activated partial thromboplastin time, ADR, Adverse reaction, lcsh:R5-920, 6-OHDA, 6-hydroxydopamine, lcsh:Cytology, HBs, Hepatitis B surface, HTLV-1, Human T-cell leukemia virus type 1, MMT, Manual muscle testing, CPK, Creatine phosphokinase, GCP, Good clinical practice, Riluzole, %FVC, Forced vital capacity, HIV, Human immunodeficiency virus, Tolerability, CRP, C-reactive protein, Original Article, CTCAE, Common terminology Criteria for Adverse Events, AST, Aspartate aminotransferase, lcsh:Medicine (General), Requip CR, BUN, Blood urea nitrogen, medicine.drug, SALS, sporadic ALS, medicine.medical_specialty, FAS, Full analysis set, Randomization, EDC, Electronic data capture, TDP-43, Transactive response DNA-binding protein 43, TPHA, Treponema pallidum hemagglutination, Biomedical Engineering, IRB, Institutional review board, Placebo, HCV, Hepatitis C virus, Biomaterials, SAE, Severe adverse effect, 03 medical and health sciences, HCG, Human chorionic gonadotropin, 8-OHdG, 8-Hydroxydeoxyguanosine, NfL, Neurofilament light chain, Internal medicine, medicine, ALSFRS-R, ALS Functional Rating Scale-Revised, Ropinirole Hydrochloride, lcsh:QH573-671, ALSAQ-40, Amyotrophic Lateral Sclerosis Assessment Questionnaire-40, AE, Adverse effect, LDH, Lactate dehydrogenase, business.industry, PPS, Per protocol set, QOL, Quality of life, ALT, Alanine aminotransferase, CK, Creatine kinase, medicine.disease, Clinical trial, FALS, Familial ALS, PT, Prothrombin time, iPSC-drug discovery, CAFS, Combined Assessment of Function and Survival, 030104 developmental biology, LDL, Low-density lipoprotein, business, 030217 neurology & neurosurgery, Progressive disease, Developmental Biology

  2. 2

    المصدر: IBRO Reports
    IBRO Reports, Vol 6, Iss, Pp 74-86 (2019)

    وصف الملف: Electronic-eCollection

  3. 3
  4. 4

    المؤلفون: Ricardo Tapia, Luis B. Tovar-y-Romo

    المصدر: ASN NEURO
    ASN Neuro, Vol 4 (2012)

    مصطلحات موضوعية: Male, Vascular Endothelial Growth Factor A, amyotrophic lateral sclerosis, Time Factors, VEGFR2, VEGF receptor 2, ChAT, choline acetyltransferase, Microdialysis, PB, phosphate buffer, SOD1, superoxide dismutase 1, Pharmacology, FALS, familial ALS, chemistry.chemical_compound, Drug Delivery Systems, Excitatory Amino Acid Agonists, rat, Amyotrophic lateral sclerosis, Motor Neurons, Cell Death, General Neuroscience, Drug Administration Routes, Neurodegeneration, neurodegeneration, ALS, amyotrophic lateral sclerosis, VEGF, vascular endothelial growth factor, Vascular endothelial growth factor, medicine.anatomical_structure, i.c.v., intracerebroventricular, BDNF, brain-derived neurotrophic factor, neuroprotection, Research Article, SALS, sporadic ALS, AMPA receptor, Motor Activity, S3, Neuroprotection, Drug Administration Schedule, Spinal Cord Diseases, lcsh:RC321-571, Choline O-Acetyltransferase, AMPA, α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid, PGE, paw grip endurance, Glial Fibrillary Acidic Protein, medicine, Animals, Paralysis, Rats, Wistar, IGF-1, insulin-like growth factor 1, lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry, alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid, Analysis of Variance, business.industry, Brain-Derived Neurotrophic Factor, GFAP, glial fibrillary acidic protein, spinal cord, Motor neuron, medicine.disease, Spinal cord, Rats, Disease Models, Animal, chemistry, Nerve Degeneration, Neurology (clinical), business, Neuroscience

  5. 5
    دورية أكاديمية

    المؤلفون: Morimoto S; Department of Physiology, Keio University School of Medicine, Japan.; Department of Neurology, Keio University School of Medicine, Japan., Takahashi S; Department of Neurology, Keio University School of Medicine, Japan., Fukushima K; Department of Physiology, Keio University School of Medicine, Japan., Saya H; Division of Gene Regulation, Institute for Advanced Medical Research, Graduate School of Medicine, Keio University, Japan., Suzuki N; Department of Neurology, Keio University School of Medicine, Japan.; Department of Neurology, Shonan Keiiku Hospital, Japan., Aoki M; Department of Neurology, Tohoku University, School of Medicine, Japan., Okano H; Department of Physiology, Keio University School of Medicine, Japan., Nakahara J; Department of Neurology, Keio University School of Medicine, Japan.

    المصدر: Regenerative therapy [Regen Ther] 2019 Jul 26; Vol. 11, pp. 143-166. Date of Electronic Publication: 2019 Jul 26 (Print Publication: 2019).

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: The Japanese Society for Regenerative Medicine. Production and Hosting by Elsevier B.V Country of Publication: Netherlands NLM ID: 101709085 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-3204 (Electronic) Linking ISSN: 23523204 NLM ISO Abbreviation: Regen Ther Subsets: PubMed not MEDLINE

  6. 6
    دورية أكاديمية

    المؤلفون: Korhonen P; A. I. Virtanen Institute for Molecular Sciences, Biocenter Kuopio, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland., Pollari E; KU Leuven, University of Leuven, Department of Neurosciences, Experimental Neurology, VIB Center for Brain & Disease Research, Box 912, B-3000 Leuven, Belgium., Kanninen KM; A. I. Virtanen Institute for Molecular Sciences, Biocenter Kuopio, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland., Savchenko E; A. I. Virtanen Institute for Molecular Sciences, Biocenter Kuopio, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland., Lehtonen Š; A. I. Virtanen Institute for Molecular Sciences, Biocenter Kuopio, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland., Wojciechowski S; A. I. Virtanen Institute for Molecular Sciences, Biocenter Kuopio, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland., Pomeshchik Y; A. I. Virtanen Institute for Molecular Sciences, Biocenter Kuopio, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland., Van Den Bosch L; KU Leuven, University of Leuven, Department of Neurosciences, Experimental Neurology, VIB Center for Brain & Disease Research, Box 912, B-3000 Leuven, Belgium., Goldsteins G; A. I. Virtanen Institute for Molecular Sciences, Biocenter Kuopio, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland., Koistinaho J; A. I. Virtanen Institute for Molecular Sciences, Biocenter Kuopio, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland., Malm T; A. I. Virtanen Institute for Molecular Sciences, Biocenter Kuopio, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland.

    المصدر: IBRO reports [IBRO Rep] 2019 Jan 11; Vol. 6, pp. 74-86. Date of Electronic Publication: 2019 Jan 11 (Print Publication: 2019).

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101691215 Publication Model: eCollection Cited Medium: Internet ISSN: 2451-8301 (Electronic) Linking ISSN: 24518301 NLM ISO Abbreviation: IBRO Rep Subsets: PubMed not MEDLINE